Thinking of joining a study?

Register your interest

Become a volunteer?

NCT06795139 | RECRUITING | Leukemia

Pilot of a Trial Enrollment Diversity Dashboard
Sponsor:

Dana-Farber Cancer Institute

Information provided by (Responsible Party):

Andrew Hantel, MD

Brief Summary:

The goal of this study is to test the feasibility of a data visualization tool called the Trial Enrollment Diversity Dashboard (TEDD) to ensure participant diversity in acute leukemia trial enrollment.

Condition or disease

Leukemia

Acute Leukemia

Intervention/treatment

Trial Enrollment Diversity Dashboard Behavioral

Phase

NA

Detailed Description:

This study is about testing a tool called the Trial Enrollment Diversity Dashboard (TEDD) to see if it can help increase diversity in cancer clinical trials, specifically for leukemia. Clinical trials are important for developing new cancer treatments, but not all groups are equally represented in these trials. This can lead to treatments that may not work as well for everyone. The TEDD tool is designed to give medical professionals feedback on how diverse their patient enrollments are clinical trials. By using this tool, medical professionals can see if they are enrolling a diverse group of patients and make changes if needed. The study will involve a small group of medical professionals who treat leukemia patients. They will use the TEDD tool and provide feedback on its usability and effectiveness. Study procedures include completion of surveys and usage of the TEDD intervention dashboard. It is expected that about 12 medical professionals will take part in this research study. Participation in this research study is expected to last about 14 months. The National Cancer Institute is providing funding for this research study.

Study Type : INTERVENTIONAL
Estimated Enrollment : 12 participants
Masking : NONE
Primary Purpose : HEALTH_SERVICES_RESEARCH
Official Title : Feasibility Pilot of a Trial Enrollment Diversity Dashboard (TEDD)
Actual Study Start Date : 2025-07
Estimated Primary Completion Date : 2026-04-01
Estimated Study Completion Date : 2026-10-01

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria Medical Professionals
  • * Physician, nurse practitioner, or physician assistant
  • -≥10% clinical effort (or one ½ day of clinic per week for those working \<1 FTE)
  • * Treats adult patients with leukemia or related diseases at the study sites
  • * Ability to understand and willingness to provide informed consent
  • * Age 18 or older
  • Inclusion Criteria Participant Population
    • * Age ≥18 years old
    • * Diagnosis of leukemia, lymphoma, myeloma, or related diseases
    • * Seen by a physician for this diagnosis at one of the study sites
    Exclusion Criteria Medical Professionals
    • -Listed member of the research team
    Exclusion Criteria Participant Population
    • -Participants without the diagnoses of interest listed above, participants not seen at the study sites.
Pilot of a Trial Enrollment Diversity Dashboard

Location Details

NCT06795139

Please Choose a site

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations

RECRUITING

United States, Massachusetts

Dana-Farber Cancer Institute

Boston, Massachusetts, United States, 02215